30
Participants
Start Date
October 25, 2018
Primary Completion Date
May 20, 2019
Study Completion Date
ASP5354
Intravenous
Placebo
Covance CRU, Daytona Beach, Daytona Beach
Astellas Pharma Global Development, Inc.
INDUSTRY